Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 19, 1989 - Issue 9
13
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Azodicarbonamide: Methods for the analysis in tissues of rats and inhalation disposition

, , &
Pages 1003-1012 | Received 18 Oct 1988, Accepted 23 Mar 1989, Published online: 22 Sep 2008
 

Abstract

1. A method has been developed for measuring azodicarbonamide (ADA) and its metabolite biurea in tissues of rat. The method is based on the reaction of ADA with triphenylphosphine; the derivative so formed was isolated and quantified using reversed-phase h.p.l.c. Quantification was by u.v. detection with 14C-ADA as internal standard. Biurea was measured by oxidation to ADA, followed by treatment as described above.

2. When biurea was added to tissues at 100–400 μg, recoveries of 92–125% were observed. In contrast, recoveries of ADA added to tissues were generally much less than 100% and could not be reliably determined. The inability to quantify ADA added to tissues was ascribed to its rapid and facile reduction by tissue sulphydryl groups.

3. When rats were exposed to ADA aerosol concentrations of 200, 100, 50 and 0 mg/m3 for 13 weeks by inhalation, a non-linear dose-dependent accumulation of biurea was observed in lungs. No ADA was detected in lungs. Neither biurea nor ADA could be detected in kidneys.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.